Inpharma Weekly

, Volume 963, Issue 1, pp 14–14 | Cite as

No advantage with IP cisplatin

Newsletter Article


Ovarian Cancer Disease Recurrence Thiosulfate Evaluable Patient Intraperitoneal Chemotherapy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Adis International Ltd 1994

Personalised recommendations